GI Journal Club – April 22, 2021
Article 1: Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome N Engl J Med 2021;384:818-28 DOI: 10.1056/NEJMoa2008290 Summary: The CONFIRM trial was performed to determine if administration of Terlipressin is more effective than placebo in improving renal function in patients with cirrhosis and HRS type 1. Fellow Presenter: April Wall Article […]
